Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Must Capital Inc V.MUST.H

Must Capital Inc. is a Canada-based company, which is focused on identifying active business interests, both within and outside of the software industry. The Company has not identified or selected any additional specific investment opportunity or business.


TSXV:MUST.H - Post by User

Post by illumination1on Jan 18, 2017 5:18pm
66 Views
Post# 25725167

Sizing Things Up!

Sizing Things Up!I am definitely no stranger to medical imaging/screening devices. I followed one to some extent and invested in another in the late 1990's early 2000. Both of the companies were Canadian. The one that I was following traded on the low of .50 to a high of $2.50 and it is still around today called Medmira or mir is the ticker you can look it up and see where it is trading now and how many outstandings it has which is really ugly--nearly 660 million but back then it was like 30 or so million. Medmira was a rapid screening device for Hiv and Aids and was cutting edge which reached a certain level of success and acclaimation of recognition and awards--if i am remembering correctly it was a Nova Scotia based company.  The other company that I held shares in was initially called MDX Medical prior to later changing its name and focus to Uro-Nirs. MDX started out as a non-invasive medical device "universal phantom" which scanned a person's body to detect cancer. The device was placed from my recollection in a Swedish centre i believe in Swedan as for testings. But as the company thought it was not necessarily in the right market and that other similar devices were already being used in the US it shifted its focus to testing for urinary tract infection and other related diseases including erectile dysfunction etc. The company along with a scientific team at UBC  (University of British Columbia Canada)worked on the new direction and the screening tests which were to eliminate the more invasive, painful, and embarassing circumstances surrounding the conventional cathode testings which were also very time consuming and expensive. As MDX the company traded as high .40 but towards the end it diminished badly and couldn't succeed in its market objectives where the company's ip was sold to the Chinese. The two common threads with both Uro-nirs and Medmira was the market and more specifically their inabilities to pentrate successfully into the American one which given where this company is positioned isn't going to be as much of a problem as it was for the other two--no where as problematic. Nevertheless, I have stated very clearly there are lots of imaging companies. If you go to sedar and look under i you will see there are at least 5 you can readily see if not more. Again, as I also clearly stated there is competition in everything so if one is afraid of this don't bother investing. The bottom line is for companies to build their brand, differentiate themesleves from the others and show why they are the better option. This company by the looks of it was a privately held one and is transitioning to being publicly traded as can be seen when doing a charting search--go and you will see it is been trading or at least recognized in between 2014 and 2015 as the start date. Any company which is starting is likely to have deficit until sales pick up traction which to become profitable depending on the amounts of revenue earned can take anywhere between 3-5 years to establish it on the the short term and may well go longer term never being profitable as are many if not the majority of venture companies so there is nothing unusual here. With this being said, this equity fell from .30 52 week high to where it sits today at .035 prior to me buying on mass. Go back and check Mir's share price and proportion to its outstandings--guess where it trades .025. Over here we have way less shares than over there at 660 million shares and are trading now at .04--when you do the math and if we see this at 70 million fully diluted versus 660 million that is almost 10 times fewer shares and if we look at proportions that would mean that this should trade around .25 all things being equal and in sense and sensibility but the stock market is anything but that. Nevertheless, having trade at .035 prior to my mass buying is by far very disproportionate to that of Mir. Folks, even at .05-.10 this is a really good buy and has the big advantage of already being tested and available in the US market. In any case, we will just have to wait and see where things go and what the company is able to establish with its longer term goal--only time will tell but i will be here for the longer haul to give company a fair chance to prove what i see in it right now--being very successful and striving to get to the Nasdaq. glta
<< Previous
Bullboard Posts
Next >>